Healthcare-focused SPAC Sarissa Capital Acquisition announced that, starting today , shareholders may elect to trade the company’s Class A ordinary shares and warrants separately. Shares and warrants that are separated will trade on the Nasdaq under “SRSA” and “SRSAW,” respectively. Units not separated will continue to trade under “SRSAU.”
Sarissa raised $175 million in an October IPO.
The company’s sponsor, Sarissa Capital Acquisition Sponsor, was capitalized by investment funds managed by Sarissa Capital Management, which was founded by Alex Denner. Read more.
